Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)

Dr. Rick A. Martin

Medical Genetics
1 Childrens Pl, 
Saint Louis, MO 
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
1 Childrens Pl, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rick Martin is a Medical Genetics provider in Saint Louis, Missouri. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Fabry Disease and Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome).

His clinical research consists of co-authoring 1 peer reviewed article and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 2 clinical trials in the study of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome).

Specialties
Medical Genetics
Licenses
Clinical Genetics in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Alliance
  • EPO
  • HMO
  • POS
  • PPO

Locations

1 Childrens Pl, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Open Label Clinical Trial of Replagal Enzyme Replacement Therapy In Children With Fabry Disease Who Have Completed Study TKT023 or Who Are Naive to Enzyme Replacement Therapy
An Open Label Clinical Trial of Replagal Enzyme Replacement Therapy In Children With Fabry Disease Who Have Completed Study TKT023 or Who Are Naive to Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: July 30, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

1 Total Publications

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 15, 2010
Similar Doctors
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Dorothy K. Grange
Medical Genetics | Pediatrics
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Dorothy K. Grange
Medical Genetics | Pediatrics

Washington University

1 Childrens Pl, 
Saint Louis, MO 
 (0.1 miles away)
314-273-1006
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dorothy Grange is a Medical Genetics specialist and a Pediatrics provider in Saint Louis, Missouri. Dr. Grange is rated as a Distinguished provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Phenylketonuria (PKU), Aplasia Cutis Congenita, Clouston Syndrome, and Ectodermal Dysplasias. Dr. Grange is currently accepting new patients.

Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Stephen R. Braddock
Medical Genetics | Pediatrics
Experienced in Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Dr. Stephen R. Braddock
Medical Genetics | Pediatrics

Ssm Health Care Group

10101 Woodfield Ln, 
Saint Louis, MO 
 (7.9 miles away)
608-280-4647
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stephen Braddock is a Medical Genetics specialist and a Pediatrics provider in Saint Louis, Missouri. Dr. Braddock is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Chromosome 20 Trisomy, Coloboma, Cerebellar Hypoplasia, and CHARGE Syndrome. Dr. Braddock is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Martin's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile